KoBioLabs, Inc

₩2,615As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:348150Healthcare
Country South Korea
PE (Fwd) •••
TSR 6Y CAGR (38.49%)
Div yield —
ROE (10.02%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.06
PE TTM —
TSR TTM (48.01%)
Mkt cap ₩50.78B
ROIC (8.00%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,287
25.70%
6.29%
Hold 4|2|3|2|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
26.56
27.16
29.96
31.34
2.12%
7.25%
21.33%
16.70%
Revenue₩B
5.061
5.006
5.024
5.040
4.18%
(2.54%)
(0.07%)
0.08%
Peers (US$37.44M)
Cap (US$)
PE
38.76M
50.39x
37.84M
—
33.07M
7.715x
37.87M
—
Capital
TTM
5Y
10Y
Leveragex
0.120
0.279
0.254
EBIT/Intx
1.045
0.203
0.203
Own earn%
2.67
(46.41)
(42.51)
Sh yield%
19.96
46.02
42.99
Owners
Insiders/Inst%
12.33
53.06
Short interest%
2.66
SBC / revenue%
2.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
27–35
$1 testx
—
Incr. ROIC%
3